HealthCare Global Enterprises Ltd - 539787 - Intimation Of Earnings Call To Discuss The Audited Financial Results Of Healthcare Global Enterprises Limited
Earnings Conference Call has been scheduled on Thursday, May 26, 2022, at 6.00 pm (IST), to discuss the Audited Financial Results of the Company. HealthCare Global Enterprises Ltd - 539787 - Board Meeting Intimation for Intimation Of Meeting Of Board Of Directors Of Healthcare Global Enterprises Limited
Healthcare Global Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2022 ,inter alia, to consider and approve and take on record the Audited Financial Results (both Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2022. HealthCare Global Enterprises Ltd - 539787 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
HealthCare Global Enterprises Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here HealthCare Global Enterprises Ltd - 539787 - Scrutinizer Report
Scrutinizer Report_Postal Ballot for seeking approval of the members, for the agenda as listed in the Postal Ballot Notice dated April 01, 2022. HealthCare Global Enterprises Ltd - 539787 - Postal Ballot-Voting Results
Postal Ballot for seeking approval of the members, for the agenda as listed in the Postal Ballot Notice dated April 01, 2022. HealthCare Global Enterprises Ltd - 539787 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018. HealthCare Global Enterprises Ltd - 539787 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayHealthCare Global Enterprises Ltd 2CINL15200KA1998PLC023489 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 83.56 4Highest Credit Rating during the previous FY A+ 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)ICRA LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Sunu Manuel Designation: Company Secretary and Compliance Officer EmailId: sunumanuel@hcgel.com Name of the Chief Financial Officer: Srinivasa V Raghavan Designation: srini.raghavan@hcgel.com EmailId: srini.raghavan@hcgel.com Date: 29/04/2022 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. HealthCare Global Enterprises Ltd - 539787 - Compliances- Compliance Certificate For The Period Ended March 2022
Compliance Certificate under Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 HealthCare Global Enterprises Ltd - 539787 - Certificate Under Regulation 40 (9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended March 31, 2022
Certificate under Regulation 40 (9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the year ended March 31, 2022 HealthCare Global Enterprises Ltd - 539787 - Reconcilliation Of Share Capital Audit Report For The Quarter Ended March 31, 2022
Reconcilliation of share capital audit report for the quarter ended March 31, 2022